Skip to content

DocGo DCGO Impairment of strategic investments

Impairment of strategic investments at other companies

NuSkin Enterprises logo
NuSkin EnterprisesNUS
$0-100%
VirnetX Holding Corp
 logo
VirnetX Holding Corp VHC
$500K
Clean Energy Fuels logo
Clean Energy FuelsCLNE
$0-100%
QuinStreet logo
QuinStreetQNST
$0-100%
Veeco Instruments logo
Veeco InstrumentsVECO
$101K
LivaNova logo
LivaNovaLIVN
$1.13M

Segments

By segment

See full
Corporate$5M
Mobile Health Services$0
Transportation Services$0

Other financials

Income statement

See full
Revenue$75.6M-21.3%
Gross profit-$407.9M-25.6%
Operating income-$18.7M-33.7%
Net income-$14.8M-57.0%
EPS (diluted)-$0.15-66.7%

Balance sheet

See full
Cash & equivalents$46.8M-54.6%
Total debt$28.5M-7.6%
Total equity$132.3M-57.2%
Total assets$209.2M-51.4%

Cash flow

See full
Operating cash flow-$4.7M-151%
CapEx$430.3K-58.2%
Free cash flow-$5.1M-162%

Valuation

See full
Market cap$50.98M-67.2%
Enterprise value$32.67M-59.1%
P/S0.2×-0.2×

Profitability

See full
Operating margin-60.6%
Net margin-62.2%
FCF margin14.6%+8.1pp

Returns & leverage

See full
Return on equity-85%
Debt / equity0.2×+0.1×
Current ratio1.8×-0.7×

Where this comes from

Reported directly by DocGo in its filing.

Tagged under the XBRL concept us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount.

The official record: DocGo’s 10-K, filed March 16, 2026, on SEC EDGAR. View the filing →

Ask your AI about DocGo's impairment of strategic investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is DocGo's impairment of strategic investments?
DocGo (DCGO) reported impairment of strategic investments of $1.25M in Q4 2025.
What does impairment of strategic investments mean?
This represents non-cash impairment charges recognized on strategic equity investments that do not have a readily determinable market value. It reflects a downward adjustment in the valuation of private or non-marketable holdings due to adverse changes in the investee's financial health. This is a key indicator of risk within the company's strategic investment portfolio.